Nuheara to raise AU$3 million to ramp up production for ongoing rollout of OTC hearing aids

Dec 22, 2022

Nuheara Limited (ASX: NUH) announced that it has received strong commitments to raise AU$3 million via Placement to sophisticated and professional investors at AU$0.18 per fully paid ordinary share. The Company confirmed that its existing shareholder, and strategic investor, Realtek has committed to subscribe for AU$1.5 million under this Placement.

The fund raised via Placement will be used to ramp up production for the ongoing rollout of the NUH’s US FDA cleared over the counter hearing aids in the US.

 

 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com